Dental Claim Denials | Billing Care Solutions
How We Recovered $347K in Lost Revenue by Reducing Dental Claim Denials
August 20, 2026
Expert CPT Code 29999 Guide | Billing Care Solutions
CPT Code 29999: How to Avoid Billing Denials and Improve Arthroscopy Reimbursement
August 20, 2026

Why Infusion A/R Is Growing Faster Than Collections: How to Turn Outstanding A/R Into Faster Cash

Find out why infusion A/R Days rise faster than collections and how smarter RCM workflows reduce aging and accelerate healthcare revenue.

Proven Ways to Reduce A/R Days | Billing Care Solutions

For an infusion practice, rising A/R Days is a balance-sheet problem before it becomes a billing problem. Increased sales will result in increased receivables, which will lead to an increase in operating capital tied up in the uncollected claims. It impacts cash flow, financial planning, employee flexibility and fueling growth in a practice. So, the question for the executive is not when is the high A/R, but how much cash is stuck and what investment is going to get it.

Net Days A/R sits in the 30-60 day range and denial rate falls into the 3-5% range in the MAP framework places defined by HFMA. HFMA also monitors the following other revenue cycle metrics: billed A/R > 90 days, cash collection, charge lag and denial performance. Benchmark comparison should be more specific for a specialty infusion group. A/R should be segmented by payer, drug, site of care, age bucket, denial reason, and claim value. This transforms a wide A/R issue into a capital allocation choice that has quantifiable financial implications.

 

Schedule Free Revenue Assessment

Medical Billing Services Starting at Just 2.99% of Collections. We’re available 24/7

What A/R Days Reveal About Cash Flow

A/R Days is an estimate of the period of time that money is lying in the accounts receivable system until it is collected. Total A/R by Average Daily Revenue. For instance, if you have $1.2 million worth of A/R and $30,000 in daily revenue, your A/R Days are 40. This provides financial leaders with a helpful gauge of collection efficiency.

But A/R Days must not be judged on its own merits. A rising A/R balance may be a positive sign of business growth and not a negative sign of the A/R performance. The problem starts to happen when receivables increase at a higher rate than collections or revenue. That trend suggests that cash is coming into the practice at a slower pace.

Imagine that you start a practice with a monthly billable service of $500,000. With an additional $300,000 in collections, the gap still stands at a huge $900,000. This gap will lead to an increase in A/R balance and may even lead to the increase in A/R Days overtime. Later on, the practice requires additional operating capital to sustain its regular operations.

 

Healthy A/R Growth vs Problematic Growth

When the A/R growth is healthy, it means that there is an increase in the volume of treatment as well as revenue. The aging profile should be consistent as collections grow with additional charges. When problem balances grow more than new revenue is collected, there is a problem with problematic growth. That is a pattern that needs immediate investigation of the revenue cycle. The goal should not be reducing A/R through aggressive adjustments. Your goal should be to get these good receivables cashed much quicker. This involves pinpointing operational laggards that give rise to outstanding balances. It also involves stopping the entry of new claims into the same aging cycle.

 

Why Infusion A/R Grows Faster Than Collections

There are multiple revenue cycle stages in infusion billing. Each stage has an impact on the speed of the claim becoming collectible revenue. Delays can start before the claim is submitted to the payer. Those issues in the initial assessments then lead to more work during follow-up and denial management.

 

Slow Charge Capture Creates Initial Delays

For each infusion encounter, charge capture begins the billing process. Medications, administration services, supplies and other billable services must be accurately captured in practices. The creation of a claim is also delayed when charges are in the system late. This results in collection lag before processing of the payers even starts.

An infusion that occurs Monday for instance, may not be charged until Friday. Then coding and claim review delay the submission even further into the billing cycle. The more corrections that need to be made, the longer the five-day charge delay will be. These are minor delays in hundreds of monthly encounters.

HFMA’s revenue cycle performance measures include total charge lag. This metric can be used to pinpoint delays in the billing process from services provided to services billed in a practice. If there is a steady rise it may be due to issues with charge capture workflows. It also gives an early warning prior to those delays in aging reports.

 

Coding Errors Delay Clean Claim Submission

Infusion statements typically have more than one coding element. These include CPT codes, HCPCS codes, ICD-10-CM codes, units, modifiers and drug information. A single mistake can result in a denied or misprocessed claim. Every correction requires an additional step prior to making payment.

Coding issues also result in unnecessary staff rework. Billing teams need to detect the mistake, correct the claim and re-issue it. Other claims need to be backed up by further documents before the payer can process it. This delay will extend the days in A/R.

A good coding workflow would validate before submitting a claim. Review should verify that the reported service is consistent with the documentation and the requirements of the payers. Special attention needs to be paid to drug units, administration services, modifiers and diagnoses. Average first-pass accuracy can help to preserve clean claim performance and cash flow.

 

Prior Authorization Gaps Create Unpaid A/R

Another crucial financial gatekeeping moment for infusion practices is prior authorization. There are many specialty drugs that require approval from payers before the patient can start their treatment. The authorization must be the same as the patient, medication, service, provider, units, and approved time frame. Inaccurate or missing details can cause issues with payment following the treatment.

Teams may face authorization issues where the information is out-of-date. An authorization may lapse prior to the next scheduled infusion. Medication may also be different from the treatment authorized. These mismatches cause unnecessary claim delays and possible claim denials. Good authorization processes start before the infusion. Staff to check authorization with planned treatment and Payer requirements. They must also be able to keep track of expiration dates and acceptable amounts. Prevention is better than cure when it comes to authorization problems. 

 

Denials Move Revenue Into Older A/R

If you have a denied claim, the collection process naturally slows down and is negatively impacted. Your team needs to determine the denial reason first to correct it. There may be a need to correct, document, resubmit, or appeal the claim, depending on the problem. Each further step extends the time needed for the revenue to be collected.

The impact on the finances is greater if the denial patterns are repeated. Older balances tend to have higher staff intervention and higher number of payers escalations, with frequent denials moving balances into 61-90 day A/R and 90+ days A/R. They also add to the uncertainty of cash flow expectations.

The focus for denying the claim should be to address the root causes of the claim rather than the number of claims. Distinguish between coverage-related, documentation, coding and authorization denials. Next, rank each category according to claim volume and financial impact. This indicates the sequence of changes needed to the workflow first for these problems.

 

Weak Follow-Up Slows Collection Velocity

Submitting a clean claim does not guarantee prompt payment. Payers could ask for details, defer claims or incorrectly adjudicate claims. You need to have some workflows in place to follow up on your team to find these problems. Collectible revenue is collected for longer without consistent follow-up.

Claims with a higher value should be prioritized as they have more impact on finances. Old balances must escalate faster because of the increasing collection risk. Follow up should be based on documented timelines and escalation procedures for payers. This helps to ensure uniformity within the billing team.

A/R follow-up should also measure financial results. Monitor recovery dollars, claims settled, resolution time, and aging. These metrics indicate whether follow-up activity is having a real monetary impact. They also assist in pinpointing areas of inefficiency within their team.

 

Payment Posting Problems Distort A/R Data

Another vital revenue cycle touch point is payment posting. Payments are due to the proper accounts and should have proper contractual adjustments. Outstanding A/R can be artificially inflated due to unapplied cash and improper adjustments. This increases the unreliability of financial reporting.

Late posting also results in inaccuracies in visibility of current receivables. Even if balances are paid to the organization, leadership may still view them as unpaid. Some of the time may then be used to work accounts on which no collection action is required. When posting is done correctly, this unnecessary work is avoided.

Payments and adjustments should be reconciled consistently in practice. Unapplied cash should be reviewed and resolved regularly. Appropriate investigation should also be conducted on credit balances. Clean payment data provides leadership with a better insight into actual A/R performance.

 

Which A/R Metrics Should You Track?

A/R Days is a crucial measure at a high level. It doesn’t point to the reasons for these collection delays. Financial leaders should look at A/R Days in addition to aging, denials, clean claims, and payment metrics. These indicators are taken together to better understand the revenue cycle performance.

KPIWhat It MeasuresWhy It Matters
A/R DaysAverage collection timeShows overall collection efficiency
A/R AgingReceivables by ageIdentifies delayed revenue
Clean Claim RateClaims passing without reworkMeasures front-end accuracy
Denial RateClaims denied by payersIdentifies reimbursement problems
Net Collection RateRevenue ultimately collectedMeasures collection effectiveness
Days to PaymentTime from claim to paymentShows payment speed

Often the true situation is highlighted by the relationship between these metrics. Increases in A/R Days, along with a consistent number of denials, could be a sign of charge lag or follow-up problems. An increasing number of A/R Days with more denials indicates claim resolution issues are growing. This makes it easier to use combined KPI analysis than the following one.

 

How To Find the Real A/R Bottleneck

We have to make our A/R team work harder than just that. The first step is to determine where claims are dropping out of the revenue cycle. Afterwards, link each bottle with the impact of its finance. This allows for a more specific plan to accelerate collection.

 

Start With A/R Aging

Divide outstanding balances into practical aging categories. Common categories include current, 31 to 60, 61 to 90, and over 90 days. Recent balances often reflect normal billing cycles and payer processing times. Older balances require closer investigation and stronger intervention. Any large balance, over 90 days old, should be addressed. Look at those claims by payer, denial reason, balance, and current status. Determine if the claim requires correction, documentation, appeal or payer escalation. This transforms an old report into an effective recovery plan.

 

Segment A/R By Payer

Payer segmentation reveals problems hidden inside total A/R. Compare Medicare, Medicaid, commercial payers, and individual health plans. Look for unusually high aging or denial patterns within specific payer groups. These differences often reveal payer-specific workflow problems. One payer might create authorization-related delays. Another might generate coding or documentation issues. Your team should respond according to the specific payer pattern. This approach creates more focused follow-up and prevention strategies.

 

Review A/R By Service Type

Infusion practices often manage several revenue components within one encounter. These include medications, administration services, supplies, and other billable services. Separating these categories helps identify where revenue remains unpaid. You might find one service category consistently aging faster than others. This analysis also supports better operational decisions. If medication claims create repeated problems, review drug billing workflows. If administration services generate frequent denials, examine coding and documentation. Specific data helps you correct specific problems.

 

Analyze Denial Patterns

Denials should be grouped by root cause rather than treated as one category. Review authorization, eligibility, coding, medical necessity, documentation, and coverage issues separately. Then compare their frequency and financial impact. This shows which problems deserve immediate attention. High-dollar denial categories require financial prioritization. High-frequency categories often require process improvement. A recurring low-dollar error might still consume significant staff time. The best denial strategy considers both financial loss and operational workload.

 

Measure Follow-Up Productivity

A/R follow-up should focus on recovery rather than activity alone. Track claims worked, dollars recovered, claims resolved, and average resolution time. Also monitor changes in aging across each reporting period. These measures show whether follow-up activity is reducing outstanding revenue. Your team should also monitor recovery rates for older claims. Low recovery from aging A/R might indicate weak escalation or poor claim selection. High recovery rates suggest that follow-up resources are being directed effectively. This helps leadership allocate staff time more efficiently.

 

How To Turn Outstanding A/R Into Faster Cash

The goal is not simply to reduce the A/R balance. Your practice needs to convert collectible revenue into cash faster. That requires both prevention and targeted recovery. Each revenue cycle stage should support faster movement from treatment to payment.

 

Prioritize High-Value Aging Accounts

Do not work every outstanding claim in the same order. Rank accounts according to balance, age, payer, denial status, and recovery potential. A $50,000 claim deserves more immediate attention than a $75 balance. Financial prioritization helps your team focus limited resources where they matter most. Older high-value claims also require stronger escalation. Review the current claim status before repeating standard follow-up. Determine whether payer escalation, corrected submission, or appeal action is appropriate. This creates a more deliberate recovery strategy.

 

Strengthen Front-End Revenue Controls

Prevention is often more efficient than downstream correction. Verify eligibility before treatment and confirm authorization requirements early. Review authorization details against the planned service and medication. Accurate charge capture and documentation then support cleaner claim submission. These controls reduce preventable claim problems before they reach A/R. They also reduce rework for coding and billing teams. Your practice should therefore treat front-end processes as revenue protection controls. Stronger prevention creates fewer downstream collection problems.

 

Build Payer-Specific Follow-Up Workflows

Different payers follow different processes and response timelines. Your billing team should document those requirements clearly. Follow-up intervals should reflect claim status, payer expectations, and financial value. High-value unresolved claims should receive earlier escalation. Payer-specific workflows also improve staff consistency. Each team member follows the same process instead of relying on individual judgment. This reduces the chance of claims remaining untouched. It also creates better reporting around payer performance.

 

Create a Denial Prevention Loop

Denial management should send information back to the teams creating claims. Suppose authorization denials increase during a particular month. The next step should involve reviewing the authorization workflow and identifying the failure point. The same principle applies to coding, eligibility, and documentation denials. This creates a continuous feedback process. Billing teams identify the denial, determine its cause, and correct the workflow. Managers then monitor whether the denial category declines. The objective is to prevent the same problem from creating new A/R.

 

Improve Payment Posting Accuracy

Payment posting should remain part of the A/R improvement strategy. Payments need accurate application to patient accounts and claims. Contractual adjustments must also reflect payer agreements correctly. Unapplied cash should receive regular investigation. The visibility and quality of A/R Days will improve with accurate posting. It also ensures that no staff members work accounts that have been already paid. Ongoing reconciliation will support in detecting discrepancies earlier. These controls facilitate more accurate cash forecasting.

 

When A/R Days Signals an RCM Problem

A/R Days become more concerning when several revenue cycle indicators deteriorate together. Rising A/R Days alone might reflect temporary changes in revenue volume. Rising A/R Days combined with older balances tells a different story. Adding higher denials or weaker clean claims strengthens the warning.

Watch for these patterns:

  • A/R Days increasing across multiple reporting periods
  • 90-plus-day A/R growing faster than total A/R
  • Denial rates increasing
  • Clean claim performance declining
  • Specific payers producing older balances
  • Unapplied cash increasing
  • Claims requiring repeated resubmission
  • Low recovery rates from older A/R

These indicators should trigger deeper analysis. Leadership should review the underlying claims rather than relying only on summary reports. Identify where the revenue cycle slows down and quantify the financial effect. Then assign corrective actions to the responsible workflow.

 

In-House RCM vs Outsourced A/R Management

Many infusion practices eventually face an internal capacity problem. Billing teams handle daily claims while also managing denials, patient accounts, payer calls, and payment posting. As volume increases, older A/R often receives less attention. This creates a backlog even when the team remains fully occupied.

FactorIn-House RCMOutsourced RCM
StaffingFixed internal capacityScalable support
Payer Follow-UpDepends on team workloadDedicated follow-up workflows
Denial ManagementCompetes with daily tasksStructured denial workflows
KPI ReportingVaries by practiceCentralized performance reporting
Infusion ExpertiseDepends on internal staffSpecialized RCM support
Cost StructureSalaries and overheadService-based model

The financial comparison should extend beyond staffing costs. Consider the value of recovered A/R and reduced aging. Also consider the internal hours redirected toward patient care and administrative priorities. Outsourcing becomes more compelling when internal capacity consistently limits collection performance. However, outsourcing alone does not fix weak processes. The selected RCM partner needs defined workflows, measurable KPIs, and clear accountability. Your practice should evaluate recovery performance alongside service quality. The goal is stronger financial performance, not simply transferring billing tasks elsewhere.

 

How Billing Care Solutions Improves Infusion A/R

Billing Care Solutions approaches A/R as part of the complete revenue cycle. The objective is to prevent new receivables while resolving existing outstanding balances. This requires coordination between front-end controls and back-end collection activities. Every workflow should support faster and more accurate reimbursement. The process begins with eligibility and authorization verification. Charge capture then reflects the treatment and billable services provided. Coding and claim review support accurate submission before claims reach the payer. These steps help reduce avoidable delays at the front of the cycle.

Back-end workflows focus on denials, payer follow-up, and aging A/R Days. Payment posting and reconciliation then keep financial data accurate. Leadership reporting connects these activities with measurable performance indicators. This gives practices better visibility into where cash slows down.

Billing Care Solutions can support practices across key RCM functions, including:

  • Charge capture
  • Eligibility verification
  • Prior authorization workflows
  • Infusion coding
  • Claim submission
  • Denial management
  • A/R follow-up
  • Payment posting
  • A/R reporting

The strongest A/R strategy connects these services rather than treating them separately. A denial often starts with an earlier authorization or coding problem. An aging balance might also reflect weak follow-up rather than payer delay. Understanding these connections helps practices address the root cause.

 

Build an A/R Strategy Around Cash Velocity

Reducing A/R Days matters, but cash velocity provides the broader financial perspective. Your practice needs revenue to move efficiently from treatment through final payment. Each delay increases the time required to convert services into usable cash. That affects forecasting, staffing, and operating flexibility.

Start by measuring how long each revenue cycle stage takes. Review charge lag, claim submission timing, payer response, denial resolution, and payment posting. Then compare those measurements against A/R aging and collection performance. This creates a complete picture of where cash gets delayed.

Your A/R strategy should also balance prevention with recovery. Prevent authorization and coding errors before claims enter the billing system. Recover older balances through targeted payer follow-up and escalation. This two-sided approach protects future revenue while recovering existing cash.

 

Final Takeaway

Infusion A/R grows when earned revenue stops moving efficiently through the collection process. The causes often appear across several connected billing stages. Charge delays create an early backlog, while coding and authorization problems create claim issues. Denials and weak follow-up then push more balances into older A/R. A/R Days helps financial leaders recognize changes in collection performance. However, the metric does not identify the specific cause by itself. You need aging, denial, clean claim, payment, and payer-level data for deeper analysis. These metrics help connect financial results with operational problems.

The best approach is a combination of prevention and specific A/R recovery. Increase front-end accuracy prior to claim submission to the payer. Then reinforce follow-up on existing balances in A/R. This can accelerate the conversion of earned revenue into cash in your practice. Billing Care Solutions provides healthcare companies with the tools and expertise to enhance their billing processes and maximize their revenue cycle. If your IV practice is seeing A/R Days going up, check where claims stop moving first. Next, create a strategy for RCM based on the measurable gains you can make in your collection speed, aging, and cash flow.

 

Reduce Infusion A/R Days With Smarter RCM

Rising A/R does not always mean your practice has a revenue problem. It often means earned revenue is moving too slowly through the billing cycle. Start by identifying where claims stall and why those delays occur. Then strengthen the workflows responsible for prevention, follow-up, and recovery. Billing Care Solutions provides RCM support designed to improve billing accuracy and collection performance. A stronger A/R strategy helps practices protect revenue before claims age. It also helps recover outstanding balances before they become harder to collect.

 

FAQs About Infusion A/R Days

Which A/R segments need immediate attention?

Prioritize high-value claims with advanced aging and strong recovery potential. These balances create greater cash exposure and deserve faster payer escalation.

How does payer concentration affect A/R risk?

A high concentration of payers increases the financial risk if one payer is late to pay. Separately monitor the timing of denials, authorizations, and payment for large payers.

What does excess A/R reveal financially?

Excess A/R shows working capital trapped above your approved operating target. Calculate the variance using actual A/R Days, target A/R Days, and daily revenue.

Which denial categories create financial risk?

Focus on denials producing the highest dollar exposure and recurring write-offs. Authorization, coding, eligibility, and documentation problems often require different corrective strategies.

How should CFOs evaluate RCM investments?

Compare expected collections, released working capital, recurring savings, implementation costs, and payback periods. This creates a financial basis for approving RCM investments.

When does rising A/R require intervention?

Intervene when A/R Days rise alongside older balances, denial rates, or slower collections. These combined trends indicate declining revenue cycle efficiency and growing cash risk.

How can executives measure A/R recovery?

Track dollars recovered, aging reduction, denial resolution, and collection velocity against baseline performance. These measures show whether recovery efforts produce meaningful financial improvement.

Why should infusion A/R use payer segmentation?

Payer segmentation identifies reimbursement patterns hidden inside aggregate A/R results. It helps leadership target authorization problems, payment delays, and denial trends affecting specific payers.

How does drug-level A/R analysis help?

Drug-level analysis can determine medications causing unpaid inequities. Authorization, coding, reimbursement and payer workflows can then be optimized for more valuable revenue exposure, with leadership focused on this.

What signals justify outsourced A/R management?

Outsourcing deserves review when internal capacity limits recovery and aging remains elevated. Compare expected incremental collections against vendor costs, released capital, and implementation requirements.

Why Infusion A/R Is Growing Faster Than Collections: How to Turn Outstanding A/R Into Faster Cash

Billing Care Solutions

Leave a Reply

Your email address will not be published. Required fields are marked *